Final Patient Treated in Active Implants’ NUsurface Trials

Active Implants announced treatment of the final patient in SUN and VENUS trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain from injured or deteriorated meniscus tissue. The company is pursuing an FDA De Novo 510(k) clearance for the device.

The trials enrolled a combined 243 patients, 176 of which...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us